-
Sub-chronic Effect Of Co-administration Of Methformine And Amilodipine On Some Haematological Indices In Experimental Animal
[A CASE STUDY OF WISTAR RATS]
REFRENCES -- [Total Page(s) 4]
Page 1 of 4
-
-
-
REFERENCES
Abdel-baky, A.A., Mahmoud, A.A. and Fararh, K.M. (2013). Clinicopathological evaluation of kidney functions after cadmium administration in male Rats. Benha veterinary medical journal. 24 (1): 1-11.
Alpers, D.H. and Russell-Jones, G. (2013). Gastric intrinsic factor: The gastric and small intestinal stages of cobalamin absorption. A personal journey. Biochimie. 95(5): 989-994.
American Diabetes Association. (2009). Standards of medical care in diabetes--2009. Diabetes Care. 32(1): 13-61.
Bashar, Y.A., Tukur, H.M., Sekoni, A.A. and Hassan, W.A. (2010). Nutrition retention and haematological indicies of broiler fed seed meal as the source of protein. Nigerian Journal of Basic and Applied Science. 18(2): 285-291.
Bauman, W. A., Shaw, S., Jayatilleke, E., Spungen, A. M. and Herbert, V. (2000). Increased intake of calcium reverses vitamin B-12 malabsorption induced by metformin. Diabetes Care. 23(9): 1227-1231.
Berra, K. and Miller, N.H. (2009). Inhibiting the renin-angiotensin system: why and in which patients. Journal of the American Academy of Nurse Practitioners. 21(1): 66-75.
Bogachus, L.D. and Turcotte, L.P. (2010). Genetic downregulation of AMPK-alpha isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. America Journal of Physiology Cell Physiology. 299: 1549- 1561.
Boyle, J.G., McKay, G.A. and Fisher, M. (2010). Drugs for Diabetes: Part 1 Metformin. Britain Journal of Cardiology. 17: 231-234.
Briani, C., Dalla Torre, C., Citton, V., Manara, R., Pompanin, S., Binotto, G. and Adami, F. (2013). Cobalamin Deficiency: Clinical Picture and Radiological Findings. Nutrients. 5(11): 4521-4539.
Bristol-Myers, S. (2008). U.S. Food and Drug Administration: Glucophage (metformin hydrochloride tablets) Label Information. Lancet. 352: 854-865.
Brufani, C., Crino, A., Fintini, D., Patera, P.I. and Cappa, M. (2013). Systematic review of metformin use in obese nondiabetic children and adolescents. Hormone Research Paediatric Journal. 80: 78-85.
Burcelin, R. (2014). The antidiabetic gutsy role of metformin uncovered?. Gut. 63: 706-707.
Calvo Romero, J. M. and Ramiro Lozano, J.M. (2012). Vitamin B(12) in type 2 diabetic patients treated with metformin. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion. 59(8): 487-490.
Chen, K.K. and Anderson, R.C. (1947). The toxicity and general pharmacology of N1-p-chlorophenyl-N5-isopropyl biguanide. Journal of Pharmacology and Experiemntal Therapeutics. 91: 157-160.
Cho, Y.M. and Kieffer, T.J. (2011). New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser. Diabetologia. 54: 219-222.
Chua, D., Ignaszewski, A. and Schwenger, E. (2011). Angiotensin converting enzyme inhibitors: An ACE in the hole for everyone?. British Columbia Medical Journal. 53(5): 220-223.
Clifford, S. and Alfred, J. (2011). Atlas of comparative diagnostic and comparative hematology. (2nd Ed.). New York: Wiley-Blackwell. Pp: 18-22.
Collier, C.A., Bruce, C.R., Smith, A.C., Lopaschuk, G. and Dyck, D.J. (2006). Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. American Journal of Physiology and Endocrinology Metabolism. 291: 182-189.
Copeland, K.C., Silverstein, J., Moore, K.R., Prazar, G.E. and Raymer, T. (2013) American Academy of Pediatrics. Management of newly diagnosed type 2 Diabetes Mellitus (T2DM) in children and adolescents. Pediatrics Journal. 131: 364-382.
Dacie, J. V. and Lewis, S. M. (2006). Blood-cell morphologyin health and disease. In: Practical Haematology, (7th edition). Churchill Livingstone, Edinburgh. 87-114.
De Jager, J., Kooy, A., Lehert, P., Wulffele, M.G. and van der Kolk, J. (2010). Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. Biomedical Journal. 340: 21-81.
El-Demerdash, F.M., Yousef, M.I. Kedwany F.S. and Baghdadi, H.H. (2004). Cadmium- induced changes in lipid peroxidation, blood hematology, biochemical parameters and semen quality of male rats: protective role of vitamin E and β- carotene. Food and chemical Toxicology. 42: 1563 -1571.
REFRENCES -- [Total Page(s) 4]
Page 1 of 4
-
-
ABSRACT - [ Total Page(s): 1 ]ABSTRACTMetformin, which belongs to the biguanide class, is one of the most generally used oral hypoglycemic agents. It has been used for more than 50 years and was approved by the US Food and Drug Administration (FDA) in 1994 (American Diabetes Association, 2009) whereas Amlodipine is a long acting dihydropyridine calcium channel blocker, which is used in the treatment of angina to lower the BP (Blood pressure). the aim is to know the effect of co-administration of this two drugs in Wistar rats ... Continue reading---
APPENDIX A - [ Total Page(s): 1 ]APPENDIXAPPENDIX 1: MATERIAL USED1% Ammonium oxalate10% Formalin salineAbsorbent paperAutomatic pipetteBrilliant cresyl blueCounting chamber Cyanmethaemoglobin standardDrabkin’s ReagentEDTA sample containerHematoxylin and Eosin stainKhan tubes/rackLeisfhmann stainLight microscopeMicrohaematocrit centrifugeNormal salinePasteur pipettePipette tipsRotary microtomeSpectrophotometerTimer Turk’s solution Universal sample bottle ... Continue reading---
APPENDIX B - [ Total Page(s): 1 ]APPENDIX IITable 1: haematological parameters in control, Metformine treated and Amilodipine treated Rats (Values are expressed as mean ± Standard error of means) Group A(1): control (untreated), Group B(2): co-administration of Metformin 0.00264/ml/132g and Amlodipine 0.000849/ml/132g at a single dose for 30 daysPARAMETERS GROUP A GROUP BPacked cell volume (%) 44.16±2.83 38.47±3.53Red blood cell count (x1012/L) 7 ... Continue reading---
LIST OF TABLES - [ Total Page(s): 1 ]LIST OF TABLESTable 1: Haematological parameters in control, Co-administration of Metformin and Amlodipine treated ... Continue reading---
LIST OF FIGURES - [ Total Page(s): 1 ]LIST OF FIGURESFigure 1: Shows mechanism of action of metformin Figure 2: Shows Pie chat representation of Packed cell volume of control, Co-administration of metformin and amlodipine treated Wistar Rats Figure 3: Shows Histogram representation of Hemoglobin and red blood cell count of control, Co-administration of metformin and amlodipine treated Wistar Rats Figure 4: Shows Histogram representation of red cell indicies of control, Co-administration of metformin and amlodipine t ... Continue reading---
TABLE OF CONTENTS - [ Total Page(s): 1 ]TABLE OF CONTENTTitle page Declaration Certification Dedication Acknowledgement Table of content List of table List of figures Abstract CHAPTER ONE1.0 Introduction 1.1 Background of study 1.2 Statement of Problems 1.3 Justifications 1.4 Aims 1.5 Research Objectives 1.6 Research Hypothesis 1.7 Significance of research CHAPTER TWO2.0 Literature review 2.1 Metformin 2.1.1 ... Continue reading---
CHAPTER ONE - [ Total Page(s): 2 ]CHAPTER ONE1.0 INTRODUCTION1.1 Background of the studyMetformin, which belongs to the biguanide class, is one of the most generally used oral hypoglycemic agents. It has been used for more than 50 years and was approved by the US Food and Drug Administration (FDA) in 1994 (American Diabetes Association, 2009). Currently, many clinical practice guidelines for patients with type 2 diabetes, including the American Diabetes Association (ADA), the European Association for the Study of Diabetes ... Continue reading---
CHAPTER TWO - [ Total Page(s): 12 ]The current use of serum Vitamin B12 level relies on several different range points for Vitamin B12 status. Serum Vitamin B12 level under 148 pmol/L are said to be deficient, low/borderline levels are interpreted from levels between 148-220 pmol/L (Mazokopakis and Starakis, 2012). Normal ranges of Vitamin B12 serum range from 220- 800 pmol/L, levels that exceed this are rarely suspicious in cause, although excessive B12 serum may be a marker of myloproliferative disorders (Pernicova and Korbonit ... Continue reading---
CHAPTER THREE - [ Total Page(s): 4 ]From the above table,Km of rats= 6 Km of human= 37For Amlodipine, Human dose= 10mg/70kg 1kg=10/70 =0.14mg/kgAED of Amilodipine= 0.14×(6/37) =0.02mg/kgAverage weight of experimental Animal is 132g(0.132kg)If 0.02mg of Amlodipine is administered per kg.bw,(0.02×0.132)mg of Amlodipine was administered to ... Continue reading---
CHAPTER FOUR - [ Total Page(s): 6 ]CHAPTER FOUR4.0 Results4.1 Hematological parameter in control and test groups As summarized in table 1, the mean RBC counts were 7.62 ± 2.83 x1012/L for the control and 6.53 ± 0.57 x1012/L for co-administration of metformin and amlodipine fed groups respectively. Although, decrease in RBC counts was observed in the treated (co-administration of metformin and amlodipine) dose group, these were statistically significant compared to control groups (student t test P0.05) higher in the tr ... Continue reading---
CHAPTER FIVE - [ Total Page(s): 2 ]CHAPTER FIVE5.0 DiscussionMetformin (1,1-dimethylbiguanide) is the most widely used drug to treat type 2 diabetes, and is one of only two oral anti-diabetic drugs on the World Health Organization (WHO) list of essential medicines (American Diabetes Association, 2009). Amlodipine is a long acting dihydropyridine calcium channel blocker, which is used in the treatment of angina to lower the BP. Co-administration of Metformin and Amlodipine have been discovered to lead to vitamin B12 deficiency. Al ... Continue reading---
